Revolution Medicines, Inc.
Revolution Medicines, Inc. (RVMD) Revenue
Annual & quarterly revenue history · segment & region breakdown
RVMD · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsRevolution Medicines, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | -$0.01B | -100.00% |
| 2023-12-31 | $0.01B | -$0.02B | -67.27% |
| 2022-12-31 | $0.04B | +$0.01B | +20.38% |
| 2021-12-31 | $0.03B | -$0.01B | -31.62% |
| 2020-12-31 | $0.04B | -$0.01B | -14.10% |
| 2019-12-31 | $0.05B | +$0.03B | +148.16% |
| 2018-12-31 | $0.02B | +$0.02B | — |
| 2017-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare RVMD revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Revolution Medicines, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Revolution Medicines, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Revolution Medicines, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
RVMD revenue · 4 questionsRVMD's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Revolution Medicines, Inc. SEC filings · GAAP · Revolution Medicines, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026